Stereotaxis to Report First Quarter 2016 Financial Results on May 9, 2016
May 02 2016 - 9:00AM
Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative
technologies for the treatment of cardiac arrhythmias, today
announced that it will release financial results for its 2016 first
quarter ended March 31, 2016 on Monday, May 9, 2016 after the close
of the U.S. financial markets. The Company will host a conference
call and webcast at 4:30 p.m. Eastern Time that day to discuss the
Company’s results and corporate developments.
What: |
Stereotaxis first quarter 2016 financial results
conference call |
When: |
Monday, May 9th at 4:30 p.m. Eastern Time (1:30
p.m. PT) |
Dial In Number: |
To access the live call, dial
888-471-3843 (US and Canada) or
719-325-2472 (International) and give the
participant pass code 4919601. |
Webcast:
|
To access the live and replay webcast, please
visit the investor relations section of Stereotaxis’ website at
www.stereotaxis.com |
Call Replay: |
A replay of the call will be available
approximately two hours following the end of the call through 7:30
p.m. ET on May 16, 2016. |
Replay
Numbers: |
888-203-1112 (US and
Canada)719-457-0820 (International)Replay
passcode: 4919601 |
About Stereotaxis Stereotaxis is a healthcare
technology and innovation leader in the development of robotic
cardiology instrument navigation systems designed to enhance the
treatment of arrhythmias and coronary disease, as well as
information management solutions for the interventional lab. Over
100 issued patents support the Stereotaxis platform, which helps
physicians around the world provide unsurpassed patient care with
robotic precision and safety, improved lab efficiency and
productivity, and enhanced integration of procedural information.
Stereotaxis' core Epoch® Solution includes the Niobe® ES remote
magnetic navigation system, the Odyssey® portfolio of lab
optimization, networking and patient information management
systems, and the Vdrive® robotic navigation system and
consumables.
The core components of Stereotaxis’ systems have received
regulatory clearance in the United States, European Union, Canada,
China, Japan, and elsewhere. The V-Sono™ ICE catheter manipulator,
V-Loop™ variable loop catheter manipulator, and V-CAS™ catheter
advancement system have received clearance in the United States,
Canada, and the European Union. For more information, please visit
www.stereotaxis.com.
Press Contact:
Martin Stammer
Chief Financial Officer
314-678-6155
Investor Contact:
Todd Kehrli / Jim Byers
MKR Group, Inc.
323-468-2300
stxs@mkr-group.com